TP53 and neoplasm: Early alterations often occur in the MAPK pathway (e.g., BRAF, RAS), while subsequent mutations in TERT, TP53, and the PI3K/AKT pathway are generally associated with more aggressive tumor behavior and dedifferentiation [2].